163 related articles for article (PubMed ID: 11268485)
1. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
2. Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities.
Kusuzaki K; Shinjo H; Murata H; Takeshita H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3813-6. PubMed ID: 11268459
[TBL] [Abstract][Full Text] [Related]
3. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
4. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
5. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
6. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
[TBL] [Abstract][Full Text] [Related]
9. Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma.
Kusuzaki K; Takeshita H; Murata H; Hirata M; Hashiguchi S; Ashihara T; Hirasawa Y
Cancer; 1998 Jun; 82(12):2343-9. PubMed ID: 9635526
[TBL] [Abstract][Full Text] [Related]
10. [Application of preoperative chemotherapy to postoperative chemotherapy in malignant bone and soft tissue tumors].
Furuse K; Morimoto K; Yamamoto K; Orito T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1749-54. PubMed ID: 2730070
[TBL] [Abstract][Full Text] [Related]
11. Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
Choong PF; Nizam I; Ngan SY; Schlict S; Powell G; Slavin J; Smith P; Toner G; Hicks R
Eur J Surg Oncol; 2003 Dec; 29(10):908-15. PubMed ID: 14624787
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.
Lin J; Leung WT; Ho SK; Ho KC; Kumta SM; Metreweli C; Johnson PJ
Eur J Nucl Med; 1995 Jun; 22(6):553-5. PubMed ID: 7556302
[TBL] [Abstract][Full Text] [Related]
14. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
[TBL] [Abstract][Full Text] [Related]
15. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
[TBL] [Abstract][Full Text] [Related]
16. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.
Kunisada T; Ozaki T; Kawai A; Sugihara S; Taguchi K; Inoue H
Cancer; 1999 Sep; 86(6):949-56. PubMed ID: 10491520
[TBL] [Abstract][Full Text] [Related]
17. [Value of thallium-201 scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma].
Huang ZK; Lou C; Fang XQ
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):769-72. PubMed ID: 20021831
[TBL] [Abstract][Full Text] [Related]
18. Tumor grade-related thallium-201 uptake in chondrosarcomas.
Kaya GC; Demir Y; Ozkal S; Sengoz T; Manisali M; Baran O; Koc M; Tuna B; Ozaksoy D; Havitcioglu H
Ann Nucl Med; 2010 May; 24(4):279-86. PubMed ID: 20238186
[TBL] [Abstract][Full Text] [Related]
19. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma.
Springfield D
J Bone Joint Surg Am; 1993 Dec; 75(12):1880-1. PubMed ID: 8258559
[No Abstract] [Full Text] [Related]
20. Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.
Inaki A; Taki J; Wakabayashi H; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Ann Nucl Med; 2012 Aug; 26(7):545-50. PubMed ID: 22610389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
